Envoy Medical (Envoy Medical) Insider Ownership : 16.20 % (As of May. 24, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Envoy Medical's insider ownership is 16.20%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Envoy Medical's Institutional Ownership is 0.54%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Envoy Medical's Float Percentage Of Total Shares Outstanding is 36.56%.

Envoy Medical Insider Ownership Historical Data

The historical data trend for Envoy Medical's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Insider Ownership Chart

Envoy Medical Historical Data

The historical data trend for Envoy Medical can be seen below:

	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Insider Ownership	15.06	16.24	16.24	16.24	16.24	16.24	16.20

Envoy Medical Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.